ECSP066587A - Forma no efervescente del naproxeno sódico que comprende bicarbonato sódico - Google Patents
Forma no efervescente del naproxeno sódico que comprende bicarbonato sódicoInfo
- Publication number
- ECSP066587A ECSP066587A EC2006006587A ECSP066587A ECSP066587A EC SP066587 A ECSP066587 A EC SP066587A EC 2006006587 A EC2006006587 A EC 2006006587A EC SP066587 A ECSP066587 A EC SP066587A EC SP066587 A ECSP066587 A EC SP066587A
- Authority
- EC
- Ecuador
- Prior art keywords
- naproxen
- sodium
- weight
- effective form
- tablet core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un comprimido no efervescente de naproxeno sódico, que consta de un núcleo de comprimido y si se desea de un revestimiento de azúcar o de una película, donde el núcleo del comprimido, respecto al peso del núcleo del comprimido, se compone de un 30 hasta de un 99% en peso de naproxeno sódico y de un 70 hasta de un 1% en peso de componente de materia auxiliar, que incluye como mínimo una sustancia auxiliar básica, posee una dureza suficiente, es comparativamente pequeño y conduce a un aumento del nivel de sangre especialmente rápido y con ello a una acción analgésica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH18482003 | 2003-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP066587A true ECSP066587A (es) | 2006-10-17 |
Family
ID=34529359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2006006587A ECSP066587A (es) | 2003-10-30 | 2006-05-29 | Forma no efervescente del naproxeno sódico que comprende bicarbonato sódico |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070134317A1 (es) |
| EP (1) | EP1684728B1 (es) |
| JP (1) | JP2007509862A (es) |
| AR (1) | AR046213A1 (es) |
| AT (1) | ATE442840T1 (es) |
| BR (1) | BRPI0415624A (es) |
| CA (1) | CA2543709A1 (es) |
| CR (1) | CR8406A (es) |
| DE (1) | DE602004023220D1 (es) |
| EC (1) | ECSP066587A (es) |
| ES (1) | ES2333332T3 (es) |
| PA (1) | PA8616101A1 (es) |
| PE (1) | PE20050445A1 (es) |
| UY (1) | UY28583A1 (es) |
| WO (1) | WO2005041938A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008500288A (ja) * | 2004-05-28 | 2008-01-10 | イメイジノット ピーティーワイ エルティーディー | 経口治療用化合物の供給系 |
| RU2403033C2 (ru) | 2005-03-22 | 2010-11-10 | Лозан Фарма Гмбх | Солюбилизированный ибупрофен |
| EP3449928A1 (en) | 2005-11-28 | 2019-03-06 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| GB201506755D0 (en) * | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| US11278506B2 (en) * | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
| JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
| JP7163015B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 経口固形組成物 |
| US11779541B2 (en) | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| US5034416A (en) * | 1988-01-19 | 1991-07-23 | Smith Walton J | Carboxylic acid compositions |
| PT96229B (pt) * | 1989-12-22 | 1998-06-30 | Syntex Pharma Int | Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico |
| US5358717A (en) * | 1989-12-22 | 1994-10-25 | Syntex (U.S.A.) Inc. | Directly-compressible naproxen or naproxen sodium compositions |
| IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
| GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
| US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| JPH10298072A (ja) * | 1997-04-17 | 1998-11-10 | Panacea Biotec Ltd | 非ステロイド性抗炎症剤の遷移金属錯体 |
| NZ333474A (en) * | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
| US6165506A (en) * | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| US6383515B2 (en) * | 1999-05-28 | 2002-05-07 | Sawyer Maryjean | Solvent system for enhancing solubility |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2002083110A2 (en) * | 2001-04-10 | 2002-10-24 | Zagros Pharma, Inc. | Animal model for evaluating analgesics |
| US20020192161A1 (en) * | 2001-04-10 | 2002-12-19 | Fahkreddin Jamali | Animal model for evaluating analgesics |
-
2004
- 2004-10-27 UY UY28583A patent/UY28583A1/es not_active Application Discontinuation
- 2004-10-27 PE PE2004001035A patent/PE20050445A1/es not_active Application Discontinuation
- 2004-10-28 PA PA20048616101A patent/PA8616101A1/es unknown
- 2004-10-28 AR ARP040103936A patent/AR046213A1/es not_active Application Discontinuation
- 2004-10-29 JP JP2006537031A patent/JP2007509862A/ja active Pending
- 2004-10-29 BR BRPI0415624-2A patent/BRPI0415624A/pt not_active IP Right Cessation
- 2004-10-29 ES ES04761983T patent/ES2333332T3/es active Active
- 2004-10-29 AT AT04761983T patent/ATE442840T1/de not_active IP Right Cessation
- 2004-10-29 CA CA000000008A patent/CA2543709A1/en not_active Abandoned
- 2004-10-29 US US10/577,197 patent/US20070134317A1/en not_active Abandoned
- 2004-10-29 DE DE602004023220T patent/DE602004023220D1/de active Active
- 2004-10-29 WO PCT/CH2004/000655 patent/WO2005041938A1/en active Application Filing
- 2004-10-29 EP EP04761983A patent/EP1684728B1/en active Active
-
2006
- 2006-05-15 CR CR8406A patent/CR8406A/es not_active Application Discontinuation
- 2006-05-29 EC EC2006006587A patent/ECSP066587A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007509862A (ja) | 2007-04-19 |
| DE602004023220D1 (de) | 2009-10-29 |
| ATE442840T1 (de) | 2009-10-15 |
| PA8616101A1 (es) | 2005-08-04 |
| UY28583A1 (es) | 2005-05-31 |
| EP1684728A1 (en) | 2006-08-02 |
| WO2005041938A1 (en) | 2005-05-12 |
| CR8406A (es) | 2008-04-25 |
| CA2543709A1 (en) | 2005-05-12 |
| PE20050445A1 (es) | 2005-06-18 |
| US20070134317A1 (en) | 2007-06-14 |
| ES2333332T3 (es) | 2010-02-19 |
| AR046213A1 (es) | 2005-11-30 |
| EP1684728B1 (en) | 2009-09-16 |
| BRPI0415624A (pt) | 2006-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066587A (es) | Forma no efervescente del naproxeno sódico que comprende bicarbonato sódico | |
| UY33397A (es) | Forma sólida de un naftaleno carboxamida | |
| AR054060A1 (es) | Forma de dosificacion farmaceutica unitaria | |
| CL2008001879A1 (es) | Compuestos derivados de isaxolinas-naftalen-carboamida; y el uso de los compuestos en el control de plagas de invertebrados en animales. | |
| CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
| CL2011001295A1 (es) | Compuestos derivados de 1h-pirazol-4-carboxamida; metodo de control o prevencion de una infestacion de plantas utiles por microorganismos fitopatogenos; composicion pesticida que comprende a dichos compuestos. | |
| GT201000008A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
| SV2006002131A (es) | Uso de un anticuerpo para el tratamiento de lupus | |
| NI201100068A (es) | Combinación de una insulina y un agonista de glp-1. | |
| AR041428A1 (es) | Forma de dosificacion de ibuprofeno sodico | |
| CR9220A (es) | Terapia combinatoria para el tratamiento de la diabetes y de condiciones relacionadas con la misma o para el tratamiento de condiciones mejoradas aumentando un nivel de glp-1 en sangre. | |
| CL2008003116A1 (es) | Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras. | |
| GT200500179BA (es) | Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados | |
| CR11581A (es) | Composiciones en forma de comprimidos bucodispersables de temazepan | |
| CY1111800T1 (el) | Συνδυασμοι δραστικων ουσιων με νηματοδοκτονες, εντομοκτονες και μυκητοκτονες ιδιοτητες με βαση τριφθοροβουτενυλικες ενωσεις | |
| GT200600046A (es) | Terapia de combinacion | |
| CL2007001749A1 (es) | Compuesto derivado de 2-arilamino-4-(heterociclo)aminopirimidina, inhibidores de la proteina quinasa c-alfa; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes, cancer, enfermedad cardiaca coronaria, aterosclerosis, entre otras. | |
| NI200800175A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias. | |
| UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
| UY29417A1 (es) | Agentes endoparasiticidas | |
| ES2616301T3 (es) | Composición que comprende isotiocianato de alilo que tiene una actividad que impide la germinación | |
| CL2009001328A1 (es) | Compuestos derivados de 3-oxo-isoindolin-1-carboxamida, moduladores del canal de sodio nav1,7; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de un trastorno del dolor. | |
| PE20211864A1 (es) | Uso de lecitinas como biocida contra artropodos | |
| CL2007002712A1 (es) | Metodo para el tratamiento de un mamifero que sufre de osteoartritis que comprende administrar un agonista de lxr que modula la expresion del gen sensible lxr; y uso de un agonista lxr para el tratamiento o prevencion de la osteoartritis. | |
| UY28247A1 (es) | Compuestos de benzopirano para uso en el tratamiento y la prevención de afecciones relacionadas con la inflamación. |